<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED STATEMENT OF EARNINGS AND BALANCE SHEETS OF ALLERGAN, INC. AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH REPORT ON FORM 10-Q FOR THE QUARTER ENDED JUNE 27, 1997. </LEGEND> <MULTIPLIER> 1,000 <CURRENCY> US DOLLARS <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1997 <PERIOD-START> JAN-1-1997 <PERIOD-END> JUN-27-1997 <EXCHANGE-RATE> 1 <CASH> 125,500 <SECURITIES> 0 <RECEIVABLES> 223,400 <ALLOWANCES> 8,200 <INVENTORY> 139,900 <CURRENT-ASSETS> 597,800 <PP&E> 584,400 <DEPRECIATION> 244,500 <TOTAL-ASSETS> 1,327,500 <CURRENT-LIABILITIES> 359,200 <BONDS> 173,400 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 700 <OTHER-SE> 741,800 <TOTAL-LIABILITY-AND-EQUITY> 1,327,500 <SALES> 540,700 <TOTAL-REVENUES> 540,700 <CGS> 192,700 <TOTAL-COSTS> 192,700 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 1,700 <INTEREST-EXPENSE> 4,700 <INCOME-PRETAX> 54,900 <INCOME-TAX> 15,900 <INCOME-CONTINUING> 39,200 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 39,200 <EPS-PRIMARY> 0.60 <EPS-DILUTED> 0.60